The global “Immune Thrombocytopenia Market” is likely to derive growth from recent advancements in treatment methods of the disease. According to a report published by Fortune Business Insights, titled “ Immune Thrombocytopenia Market Size, Share & Industry Analysis, By Type (Acute Immune Thrombocytopenia, and Chronic Immune thrombocytopenia), By Treatment (Thrombopoietin Receptor Agonist, Immunoglobulins, Corticosteroids, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others) and Regional Forecast, 2019-2026,” the market was valued at USD 2.99 Billion in 2018, and is projected to reach USD 3.33 Billion by 2026, exhibiting a CAGR of 0.54% during the forecast period.

Immune thrombocytopenia is a serious blood disorder that occurs due to physical injuries, infections, deficiencies, and other wounds. The adverse effects of the disease have led to a high emphasis on the research and development of newer drugs and therapeutic procedures associated with the treatment of the disease. Growing emphasis on R&D will attract huge investments and yield better products. The increasing number of product launches, coupled with advancements in betterment of existing products will have a direct impact on the growth of the market tin the coming years. Although there are very few options available for treatment of the disease, advancements in ongoing clinical trials have shown promise.

The report segments the market based on disease type, treatment type, and regional demographics. Several aspects of the market have been discussed in detail, with focus on growth drivers, leading product types, and major companies. The report highlights key companies that are operating in the market and projects companies that are likely to lead the market in the coming years. Besides this, forecast figures of the market have been drawn through extensive research analysis methods, for the period of 2019-2026.

Major Immune Thrombocytopenia Market Key players covered in the report include:

  • Amgen Inc.
  • Novartis AG
  • Rigel Immune Thrombocytopenia, Inc.
  • Dova Immune Thrombocytopenia
  • Grifols S.A
  • CSL Limited
  • Octapharma AG
  • Intas Immune Thrombocytopenia Ltd.
  • Saol Therapeutics

Get Request a Sample Copy of the Immune Thrombocytopenia Report:

https://www.fortunebusinessinsights.com/enquiry/sample/immune-thrombocytopenia-itp-market-101682

Our research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers and acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.

It offers figurative estimations for upcoming years on the basis of the recent developments and historic data. For gathering information and estimating revenue for all segments, researchers have used top-down and bottom-up approaches. On the basis of data collected from primary and secondary research and trusted data sources the report will help both existing and new aspirants for market to figure out and study the market’s needs, market size, and competition.

Immune Thrombocytopenia Market Analysis 2021:

North America to Emerge Dominant in the Coming Years

Based on regional demographics, the market has been segmented into North America, Latin America, Europe, the middle East and Africa, and Asia Pacific. Among these regions, the market in North America will witness the highest growth in the coming years, driven by easier access to treatment and favourable reimbursement policies. Additionally, the presence of major market players, improving healthcare infrastructure, and growing awareness of blood disorders will have a positive influence on market growth. The ITP market in North America was valued at USD 1.58 Billion in 2018 and is likely to increase further in the coming years.

REGIONAL ANALYSIS

North America generated a revenue of USD 1.58 Billion in 2018 and is anticipated to emerge dominant in the global market during the forecast period. Factors such as higher access to treatment of ITP, larger presence of key market players, advanced healthcare infrastructure, rising awareness of rare blood disorders are expected to positively influence immune thrombocytopenia market in North America. Moreover, increasing infrastructure facilities and higher investments in the development of novel therapeutic molecules for management of ITP in North America are also prominently anticipated to boost the adoption of immune thrombocytopenia treatment in the region during the forecast period.

The Asia Pacific is expected to witness the highest growth in terms of market value. Rising awareness about idiopathic thrombocytopenic purpura in Asia Pacific region is expected to propel the demand for thrombopoietin receptor agonist based treatment during the forecast period. Patients in India, China, Japan, and the rest of Asia Pacific are expected to adopt intravenous drugs like TPO-RA and immunoglobulins to improve the disorder. Promacta/Revolade manufactured by Novartis AG is expected to lose its patent in Japan by the end of 2021. This patent expiry is a critical determinant of the declining trend to be experienced by the TPO-RA drug class in the country. Additionally, the prospective launch of TAVALISSE in the Japanese market by 2022 could prove to be a driving factor for others treatment segment.

Have Any Query? Ask Our Experts:

https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/immune-thrombocytopenia-itp-market-101682

Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Prevalence of Immune Thrombocytopenia for Key Countries, 2018
    • Introduction of New Products / Approvals (by Major Players)
    • Recent Developments Mergers, Acquisitions and Partnerships
    • Pipeline Analysis
    • Patent Analysis
  • Global Immune Thrombocytopenia Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Type
      • Acute Immune Thrombocytopenia
      • Chronic Immune Thrombocytopenia
    • Market Analysis, Insights and Forecast – By Treatment
      • Thrombopoietin Receptor Agonists
      • Immunoglobulins
      • Corticosteroids
      • Others
    • 4 Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacy
      • Retail Pharmacy
      • Others
    • Market Analysis, Insights and Forecast – By Country
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa
    • North America Immune Thrombocytopenia Market Analysis, Insights and Forecast, 2015-2026
      • Key Findings / Summary
      • Market Analysis – By Type
        • Acute Immune Thrombocytopenia
        • Chronic Immune Thrombocytopenia
      • Market Analysis – By Treatment
        • Thrombopoietin Receptor Agonists
        • Immunoglobulins
        • Corticosteroids
        • Others
      • Market Analysis – By Distribution Channel
        • Hospital Pharmacy
        • Retail Pharmacy
        • Others
      • Market Analysis – By Country
        • U.S.
        • Canada
      • S. Immune Thrombocytopenia Market Analysis, Insights and Forecast, 2015-2026
        • Key Findings / Summary
        • Market Analysis – By Type
          • Acute Immune Thrombocytopenia
          • Chronic Immune Thrombocytopenia
        • Market Analysis – By Treatment
          • Thrombopoietin Receptor Agonists
          • Immunoglobulins
          • Corticosteroids
          • Others
        • Market Analysis – By Distribution Channel
          • Hospital Pharmacy
          • Retail Pharmacy
          • Others
        • Canada Immune Thrombocytopenia Market Analysis, Insights and Forecast, 2015-2026
          • Key Findings / Summary
          • Market Analysis – By Type
            • Acute Immune Thrombocytopenia
            • Chronic Immune Thrombocytopenia
          • Market Analysis – By Treatment
            • Thrombopoietin Receptor Agonists
            • Immunoglobulins
            • Corticosteroids
            • Others
          • Market Analysis – By Distribution Channel
            • Hospital Pharmacy
            • Retail Pharmacy
            • Others

Toc Continue…

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights Pvt. Ltd.

308, Supreme Headquarters,

Survey No. 36, Baner,

Pune-Bangalore Highway,

Pune -411045, Maharashtra, India.

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

 

Related Reports :

Post-Traumatic Headache Market

Post-Traumatic Headache Market Size

Post-Traumatic Headache Market Share

Post-Traumatic Headache Market Trends

Post-Traumatic Headache Market Growth

Pyrogen Testing Market Analysis

Pyrogen Testing Market Business Opportunities

Pyrogen Testing Market Key Players

Pyrogen Testing Market Demand

Pyrogen Testing Market Competitive Landscape

Leave a Reply

Your email address will not be published. Required fields are marked *